{"id":"https://openalex.org/W2985463566","doi":"https://doi.org/10.1097/mph.0000000000001624","title":"Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia","display_name":"Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia","publication_year":2019,"publication_date":"2019-10-29","ids":{"openalex":"https://openalex.org/W2985463566","doi":"https://doi.org/10.1097/mph.0000000000001624","mag":"2985463566","pmid":"https://pubmed.ncbi.nlm.nih.gov/31688623"},"language":"en","primary_location":{"id":"doi:10.1097/mph.0000000000001624","doi":"https://doi.org/10.1097/mph.0000000000001624","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mph.0000000000001624","pdf_url":null,"source":{"id":"https://openalex.org/S15952725","display_name":"Journal of Pediatric Hematology/Oncology","issn_l":"1077-4114","issn":["1077-4114","1536-3678"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pediatric Hematology/Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072537892","display_name":"Preethi Jeyaraman","orcid":"https://orcid.org/0000-0003-1997-7471","observed_orcids":["https://orcid.org/0000-0003-1997-7471"]},"institutions":[{"id":"https://openalex.org/I2802464703","display_name":"Max Super Speciality Hospital","ror":"https://ror.org/00e7r7m66","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2802464703","https://openalex.org/I307255591"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Preethi Jeyaraman","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, New Delhi, India","institution_ids":["https://openalex.org/I2802464703"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087233671","display_name":"Rahul Naithani","orcid":"https://orcid.org/0000-0002-8235-8588","observed_orcids":["https://orcid.org/0000-0002-8235-8588"]},"institutions":[{"id":"https://openalex.org/I2802464703","display_name":"Max Super Speciality Hospital","ror":"https://ror.org/00e7r7m66","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I2802464703","https://openalex.org/I307255591"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rahul Naithani","raw_affiliation_strings":["Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, New Delhi, India","institution_ids":["https://openalex.org/I2802464703"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072537892"],"corresponding_institution_ids":["https://openalex.org/I2802464703"],"apc_list":null,"apc_paid":null,"fwci":0.7294,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.70622474,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"42","issue":"1","first_page":"e64","last_page":"e65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/imatinib-discontinuation","display_name":"imatinib discontinuation","score":0.9120000004768372},{"id":"https://openalex.org/keywords/treatment-free-remission","display_name":"treatment-free remission","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7820000052452087},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.847000002861023},{"id":"https://openalex.org/keywords/chronic-toxicity","display_name":"chronic toxicity","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8865139484405518},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8366534113883972},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.8248282670974731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8054373860359192},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5348507165908813},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5224927067756653},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46077343821525574},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4452044367790222},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.41882017254829407},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08767649531364441},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.05640009045600891}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mph.0000000000001624","doi":"https://doi.org/10.1097/mph.0000000000001624","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mph.0000000000001624","pdf_url":null,"source":{"id":"https://openalex.org/S15952725","display_name":"Journal of Pediatric Hematology/Oncology","issn_l":"1077-4114","issn":["1077-4114","1536-3678"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pediatric Hematology/Oncology","raw_type":"journal-article"},{"id":"pmid:31688623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31688623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pediatric hematology/oncology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1503207160","https://openalex.org/W1980585654","https://openalex.org/W2062710544","https://openalex.org/W2103324778","https://openalex.org/W2278657325","https://openalex.org/W2528188718","https://openalex.org/W2619125332","https://openalex.org/W2893827411","https://openalex.org/W2922314175","https://openalex.org/W2952885451"],"related_works":["https://openalex.org/W2076095017","https://openalex.org/W3096327557","https://openalex.org/W1503207160","https://openalex.org/W3194624016","https://openalex.org/W4313578138","https://openalex.org/W4408744972","https://openalex.org/W1915791887","https://openalex.org/W1966335217","https://openalex.org/W7046663213","https://openalex.org/W2922314175"],"abstract_inverted_index":{"Chronic":[0],"myeloid":[1],"leukemia":[2],"(CML)":[3],"has":[4],"different":[5],"disease":[6],"biology":[7],"with":[8,55,84],"a":[9,45],"more":[10],"aggressive":[11],"clinical":[12],"course":[13],"in":[14,44],"children.":[15],"Achieving":[16],"treatment-free":[17,61],"remission":[18,62],"is":[19,58],"the":[20,24,70,85],"ideal":[21],"goal":[22],"for":[23,63],"pediatric":[25,46],"CML":[26,49],"population":[27],"to":[28],"avoid":[29],"long-term":[30],"toxicities":[31],"of":[32,41,48,72,80,87],"tyrosine":[33],"kinase":[34],"inhibitors.":[35],"Here,":[36],"we":[37],"present":[38],"our":[39],"experience":[40],"stopping":[42,67,86],"Imatinib":[43],"patient":[47,76],"who":[50],"had":[51,78],"excessive":[52],"weight":[53],"gain":[54],"Imatinib.":[56,88],"He":[57],"currently":[59],"maintaining":[60],"15":[64],"months":[65],"after":[66],"therapy":[68],"at":[69],"time":[71],"last":[73],"follow-up.":[74],"The":[75],"also":[77],"normalization":[79],"body":[81],"mass":[82],"index":[83]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2019-11-22T00:00:00"}